diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md
index 8d64ce48..1b4da52f 100644
--- a/pages/STOP2030___Web___Posts.md
+++ b/pages/STOP2030___Web___Posts.md
@@ -3,7 +3,7 @@
 - # REALISE study registration
 	- ## Our first, and biggest, clinic trial is registered
 	- #+BEGIN_VERSE
-	  At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has already been reviewed and approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry.
-	  This clinical trial is a Cohort Event Study aimed at evaluating both safety and effectiveness within  large populations. We expect to recruit around 20 thousand people.
+	  At STOP2030 we want to provide a pharmacological tool that helps at delivering WHO's goals for soil-transmitted helminthiasis (STH). That is why we're happy to announce that the REALISE study (Real world Evaluation of an ALbendazol-Ivermectin coformulation Safety and Effectiveness), our most ambitious clinical trial, has been approved for publication in clinicaltrials.gov and the Pan African Clinical Trial Registry.
+	  This clinical trial is a Cohort Event Study aimed at evaluating both the safety and effectiveness of our fixed-dose coformulation of albendazol and ivermectin within  large populations. We expect to recruit around 20 thousand people.
 	  
 	  #+END_VERSE
\ No newline at end of file